142 related articles for article (PubMed ID: 19763026)
21. Thallium-201 scintigraphy--a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?
Choong PF; Nizam I; Ngan SY; Schlict S; Powell G; Slavin J; Smith P; Toner G; Hicks R
Eur J Surg Oncol; 2003 Dec; 29(10):908-15. PubMed ID: 14624787
[TBL] [Abstract][Full Text] [Related]
22. Benign vs malignant soft tissue neoplasms: limitations of magnetic resonance imaging.
Sen J; Agarwal S; Singh S; Sen R; Goel S
Indian J Cancer; 2010; 47(3):280-6. PubMed ID: 20587903
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced color Doppler ultrasonography increases diagnostic accuracy for soft tissue tumors.
Oebisu N; Hoshi M; Ieguchi M; Takada J; Iwai T; Ohsawa M; Nakamura H
Oncol Rep; 2014 Oct; 32(4):1654-60. PubMed ID: 25109621
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal Extratesticular Tumors and Tumorlike Conditions: From the Radiologic Pathology Archives.
Wolfman DJ; Marko J; Gould CF; Sesterhenn IA; Lattin GE
Radiographics; 2015; 35(7):1943-54. PubMed ID: 26517315
[TBL] [Abstract][Full Text] [Related]
25. PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma.
Suzuki R; Watanabe H; Yanagawa T; Sato J; Shinozaki T; Suzuki H; Endo K; Takagishi K
Ann Nucl Med; 2005 Dec; 19(8):661-70. PubMed ID: 16444991
[TBL] [Abstract][Full Text] [Related]
26. Value of MR findings in predicting the nature of the soft tissue lesions: benign, malignant or undetermined lesion?
Soler R; Castro JM; RodrÃguez E
Comput Med Imaging Graph; 1996; 20(3):163-9. PubMed ID: 8930469
[TBL] [Abstract][Full Text] [Related]
27. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
Menendez LR; Fideler BM; Mirra J
J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
[TBL] [Abstract][Full Text] [Related]
28. [Clinical usefulness of 201Tl-chloride scintigraphy for the evaluation of metastatic bone lesions].
Fukui A; Kawamura M; Kataoka M; Fujii T; Yamamoto K; Yoshioka S; Ikezoe J
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jan; 58(1):25-33. PubMed ID: 9493430
[TBL] [Abstract][Full Text] [Related]
29. [Difference of thallium-201 kinetics between VX-2 tumors and inflammatory lesions in rabbits].
Suga K; Nishigauchi K; Fujita T; Uchisako H; Ito K; Kume N; Nakanishi T; Utsumi H; Yamada N
Kaku Igaku; 1994 Feb; 31(2):151-61. PubMed ID: 8121071
[TBL] [Abstract][Full Text] [Related]
30. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade.
Hirano T; Otake H; Kazama K; Wakabayashi K; Zama A; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344
[TBL] [Abstract][Full Text] [Related]
31. Comparison of thallium-201 uptake and retention indices for evaluation of brain lesions with SPECT.
Katano H; Karasawa K; Sugiyama N; Yamashita N; Ohkura A; Watanabe K; Kamiya K
J Clin Neurosci; 2002 Nov; 9(6):653-8. PubMed ID: 12604277
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of benign and malignant superficial soft-tissue masses using grayscale and color doppler ultrasonography.
Chiou HJ; Chou YH; Chiu SY; Wang HK; Chen WM; Chen TH; Chang CY
J Chin Med Assoc; 2009 Jun; 72(6):307-15. PubMed ID: 19541566
[TBL] [Abstract][Full Text] [Related]
33. Diaphyseal medullary stenosis with pleomorphic malignant fibrous histiocytoma of the bone: 99mTc hydroxymethylenediphosphonate and 201Tl chloride scintigraphy findings.
Miyake M; Tateishi U; Maeda T; Arai Y; Hasegawa T; Sugimura K
Ann Nucl Med; 2006 Apr; 20(3):233-6. PubMed ID: 16715956
[TBL] [Abstract][Full Text] [Related]
34. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
[TBL] [Abstract][Full Text] [Related]
35. Soft tissue masses with myxoid stroma: Can conventional magnetic resonance imaging differentiate benign from malignant tumors?
Crombe A; Alberti N; Stoeckle E; Brouste V; Buy X; Coindre JM; Kind M
Eur J Radiol; 2016 Oct; 85(10):1875-1882. PubMed ID: 27666630
[TBL] [Abstract][Full Text] [Related]
36. The usefulness of serum thyroglobulin levels and Tl-201 scintigraphy in differentiating between benign and malignant thyroid follicular lesions.
Tamizu A; Okumura Y; Sato S; Takeda Y; Maki K; Hiraki T; Akaki S; Kuroda M; Kanazawa S; Hiraki Y
Ann Nucl Med; 2002 Apr; 16(2):95-101. PubMed ID: 12043914
[TBL] [Abstract][Full Text] [Related]
37. The role of nuclear medicine in primary bone and soft tissue tumors.
Abdel-Dayem HM
Semin Nucl Med; 1997 Oct; 27(4):355-63. PubMed ID: 9364645
[TBL] [Abstract][Full Text] [Related]
38. Adipose tumors of soft tissues.
Roth D; Widelec J; Ramon F; Bellemans M
J Belge Radiol; 1992 Aug; 75(4):321-6. PubMed ID: 1459933
[TBL] [Abstract][Full Text] [Related]
39. [99mTc pertechnetate scintigraphy for malignant soft-tissue tumors].
Abe H; Terui S
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Nov; 55(14):996-7. PubMed ID: 8570398
[TBL] [Abstract][Full Text] [Related]
40. Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors.
Tuncbilek N; Karakas HM; Okten OO
Eur J Radiol; 2005 Mar; 53(3):500-5. PubMed ID: 15741025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
